当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Yaron River and Shelly Aharony
Background: Previous studies have shown that computerized mobilization of the cervical spine (CMCS) is safe and potentially effective treatment for chronic neck pain (CNP).
Objective: The investigation of safety, clinical outcome, and changes of specific physiological parameters, in CNP patients, treated with individualized, 3-dimensional CMCS.
Participants: Nine patients with CNP.
Interventions: A cradle capable of CMCS was utilized. Each participant underwent individualized treatment sessions, lasting 20 min each, carried out biweekly over 6 weeks.
Main Outcome Measurements: Pain visual analog scale (VAS), Neck disability index (NDI), pressure pain thresholds (PPT), cervical range of motion (CROM), joint position error (JPE), forward neck tilt (FNT), and flexion relaxation ratio (FRR).
Results: Minor side effects encountered during the study. Comparing baseline measurements with measurements after treatment completion: VAS scores dropped by 2.3 points (p=0.04). NDI improved, but this improvement was not significant (p=0.086). CROM increased, on the average, by 11% but this increase was insignificant (p=0.061). JPE decreased from 2.88° to 1.14° (p<0.01). PPT increased from 1.27 kg/cm2 to 2.44 kg/cm2 (p=0.043). FNT insignificantly decreased from 20.36 cm to 19.02 cm (p=0.104). Left-sided FRR significantly increased (p=0.017).
Conclusions: This study provides preliminary evidence that suggest that personalized, 3-dimensional, CMCS is a safe treatment. This novel treatment may positively change cervical neuromuscular control, and the processing of proprioceptive and nociceptive information.